Cao Dong-Zi, Wang Cun-Liang, Qing Zhong, Liu Lie-Dong
Department of Orthopedics, Yangling Demonstration Zone Hospital, Yangling.
Department of Joint, Honghui Hospital, Xi'an Jiaotong University, Xi'an.
Medicine (Baltimore). 2019 Feb;98(7):e14506. doi: 10.1097/MD.0000000000014506.
This systematic review aims to explore the effectiveness and safety of extracorporeal shock-wave therapy (ESWT) for patients with frozen shoulder.
The sources of Cochrane Central Register of Controlled Trials, EMBASE, MEDLINE, Cumulative Index to Nursing and Allied Health Literature, Web of Science, Allied and Complementary Medicine Database, Chinese Biomedical Literature Database, and Websites of Clinical Trials Registry will be searched. All databases and other sources will be searched from inception to the date of the search will be run. Only randomized controlled trials of ESWT for frozen shoulder will be considered for inclusion in this systematic review. Two authors independently screen the studies, extract the data, and evaluate the methodology quality for included trials. If sufficient trials will be included with fair heterogeneity, the data will be pooled, and the meta-analysis will be performed by using RevMan 5.3 software.
This systematic review will assess the effectiveness and safety of ESWT for frozen shoulder. The primary outcome includes pain intensity. The secondary outcomes consist of shoulder function, quality of life, and also the adverse events.
Its findings may provide latest evidence of ESWT for the treatment of frozen shoulder.
No research ethics approval is required in this study, because it is a systematic review and will not use individual data. The results of this study are expected to publish at peer-reviewed journals.
本系统评价旨在探讨体外冲击波疗法(ESWT)治疗肩周炎患者的有效性和安全性。
将检索Cochrane对照试验中心注册库、EMBASE、MEDLINE、护理学与健康相关文献累积索引、科学引文索引、补充与替代医学数据库、中国生物医学文献数据库以及临床试验注册网站。所有数据库和其他来源将从创建到检索日期进行检索。本系统评价仅纳入ESWT治疗肩周炎的随机对照试验。两名作者独立筛选研究、提取数据并评估纳入试验的方法学质量。如果纳入足够数量的试验且异质性适中,将对数据进行合并,并使用RevMan 5.3软件进行荟萃分析。
本系统评价将评估ESWT治疗肩周炎的有效性和安全性。主要结局包括疼痛强度。次要结局包括肩部功能、生活质量以及不良事件。
其研究结果可能为ESWT治疗肩周炎提供最新证据。
本研究无需研究伦理批准,因为它是一项系统评价,不会使用个体数据。本研究结果预计将发表在同行评审期刊上。